Genetic Analysis Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of GEAN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,157,0578.42%
Institutions6,294,51612.7%
Public Companies10,928,29822.1%
Private Companies13,221,79026.8%
General Public14,781,61029.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.3%.


Top Shareholders

Top 25 shareholders own 69.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.3%
Bio-Rad Laboratories, Inc.
9,504,458NOK 4.9m0%no data
11.8%
Avanza Fonder AB
5,827,677NOK 3.0m0%no data
4.26%
Muen Invest AS
2,101,794NOK 1.1m0%no data
3.79%
Lucellum AS
1,872,419NOK 969.9k0%no data
3.54%
S. Munkhaugen As
1,750,116NOK 906.6k0%no data
2.88%
Biohit Oyj
1,423,840NOK 737.5k0%no data
2.54%
Ochrino As
1,256,017NOK 650.6k0%no data
2.4%
LJM AS
1,185,202NOK 613.9k0%no data
2.14%
Stella Invest AS
1,059,232NOK 548.7k0%no data
2.1%
Ole Baksaas
1,036,499NOK 536.9k0%no data
2.02%
Kagge AS
999,367NOK 517.7k0%no data
1.72%
Tore Grøttum
847,754NOK 439.1k0%no data
1.61%
Ronny Hermansen
794,700NOK 411.7k0%no data
1.49%
Erik Gjone
735,000NOK 380.7k0%no data
1.31%
Molver AS
644,673NOK 333.9k0%no data
1.15%
Per Anton Invest As
567,910NOK 294.2k0%no data
0.95%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
466,839NOK 241.8k0%0.01%
0.87%
Jama Holding AS
429,351NOK 222.4k0%no data
0.86%
Bjelland Capital I AS
423,077NOK 219.2k0%no data
0.85%
Rolfs Holding AS
420,791NOK 218.0k0%no data
0.52%
T.K. Brøvig As
258,390NOK 133.8k0%no data
0.51%
Lemica AS
253,451NOK 131.3k0%no data
0.33%
Anne Camilla Bondesson
165,042NOK 85.5k0%no data
0.32%
Christina Casen
160,489NOK 83.1k0%no data
0.32%
Per Matsson
156,582NOK 81.1k0%no data